alpha-aminopyridine has been researched along with Cough in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Keechilat, P; Kunoor, A; Pushpa Ragahavan, R; Rajendran, A | 1 |
| Gao, X; Wei, W; Xu, F; Zhao, L; Zhuang, J | 1 |
| Balfour-Lynn, IM | 1 |
| Branà, MP; Clay, E; Page, C; Patacchini, R; Preti, D; Spina, D; Trevisani, M | 1 |
| Goss, CH; Huang, X; Konstan, MW; Lubarsky, B; Marigowda, G; Mayer-Hamblett, N; McKone, EF; Millar, SJ; Morgan, W; Moss, RB; Pasta, DJ; Rubin, J; Sawicki, GS; Tian, S; Waltz, D | 1 |
| Ao, H; Bhattacharya, A; Chaplan, SR; Dubin, AE; Maher, MP; Nasser, N; Scott, BP; Shankley, NP; Swanson, DM; Wickenden, AD | 1 |
| Dunkman, WB; Franciosa, JA; Wilen, MM | 1 |
1 review(s) available for alpha-aminopyridine and Cough
| Article | Year |
|---|---|
Clinical papers of the year 2018 - Cystic fibrosis.
Topics: Administration, Inhalation; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Azithromycin; Benzodioxoles; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Chloride Channel Agonists; Cough; Cross Infection; Cystic Fibrosis; Disease Progression; Drug Combinations; Drug Therapy, Combination; Humans; Indoles; Lung Transplantation; Microbiological Techniques; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nebulizers and Vaporizers; Proton Pump Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic; Specimen Handling; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
1 trial(s) available for alpha-aminopyridine and Cough
| Article | Year |
|---|---|
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.
Topics: Adolescent; Aminophenols; Aminopyridines; Benzodioxoles; Child; Cough; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Forced Expiratory Volume; Homozygote; Humans; Lung; Male; Mutation; Quinolones; Time; Treatment Outcome; Young Adult | 2017 |
5 other study(ies) available for alpha-aminopyridine and Cough
| Article | Year |
|---|---|
Ribociclib-associated organising pneumonia.
Topics: Aminopyridines; Cough; Dyspnea; Humans; Middle Aged; Pneumonia; Purines | 2021 |
Cross-effect of TRPV1 and EP3 receptor on coughs and bronchopulmonary C-neural activities.
Topics: Aminopyridines; Animals; Bronchi; Capsaicin; Citric Acid; Cough; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Guinea Pigs; Ion Channel Gating; Male; Models, Biological; Nerve Fibers, Unmyelinated; Nodose Ganglion; Piperazines; Protein Kinase Inhibitors; Pulmonary Ventilation; Receptors, Prostaglandin E, EP3 Subtype; Sensory Receptor Cells; TRPV Cation Channels; Vagus Nerve | 2021 |
Ozone-Induced Hypertussive Responses in Rabbits and Guinea Pigs.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitussive Agents; Benzamides; Bronchoconstriction; Bronchodilator Agents; Capsaicin; Citric Acid; Cough; Cyclopropanes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Guinea Pigs; Male; Neutrophil Infiltration; Oxidants, Photochemical; Ozone; Propylene Glycols; Rabbits; Transient Receptor Potential Channels | 2016 |
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs.
Topics: Aminopyridines; Animals; Antitussive Agents; CHO Cells; Cough; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Female; Guinea Pigs; Male; Piperazines; TRPV Cation Channels | 2007 |
Adverse effects of long-term amrinone administration in congestive heart failure.
Topics: Abdomen; Aged; Aminopyridines; Amrinone; Cough; Heart Failure; Humans; Liver Function Tests; Male; Middle Aged; Nausea; Pain; Time Factors; Vomiting | 1983 |